169 related articles for article (PubMed ID: 37900425)
1. miRNA Associated With Glucose Transporters in Oral Squamous Cell Carcinoma: A Systematic Review.
R P; Yuwanati M; Sekaran S; M S
Cureus; 2023 Sep; 15(9):e46057. PubMed ID: 37900425
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of glucose transporters in human oral squamous cell carcinoma cells.
Paolini R; Moore C; Matthyssen T; Cirillo N; McCullough M; Farah CS; Botha H; Yap T; Celentano A
J Oral Pathol Med; 2022 Sep; 51(8):679-683. PubMed ID: 35920070
[TBL] [Abstract][Full Text] [Related]
3. The Role of Glucose Transporters in Oral Squamous Cell Carcinoma.
Botha H; Farah CS; Koo K; Cirillo N; McCullough M; Paolini R; Celentano A
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439735
[TBL] [Abstract][Full Text] [Related]
4. GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma.
Ayala FR; Rocha RM; Carvalho KC; Carvalho AL; da Cunha IW; Lourenço SV; Soares FA
Molecules; 2010 Apr; 15(4):2374-87. PubMed ID: 20428049
[TBL] [Abstract][Full Text] [Related]
5. The Association of miRNA10a and Glucose Transporters in Oral Squamous Cell Carcinoma With Diabetes: A Pilot Study.
R S; R P; Jayaraman S; Palati S
Cureus; 2024 Jan; 16(1):e51752. PubMed ID: 38318595
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
Kunkel M; Reichert TE; Benz P; Lehr HA; Jeong JH; Wieand S; Bartenstein P; Wagner W; Whiteside TL
Cancer; 2003 Feb; 97(4):1015-24. PubMed ID: 12569601
[TBL] [Abstract][Full Text] [Related]
7. miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.
Chen YH; Song Y; Yu YL; Cheng W; Tong X
Oncol Lett; 2019 Jun; 17(6):5441-5446. PubMed ID: 31186763
[TBL] [Abstract][Full Text] [Related]
8. Glucose transporters GLUT1, GLUT3, and GLUT4 have different effects on osteoblast proliferation and metabolism.
Arponen M; Jalava N; Widjaja N; Ivaska KK
Front Physiol; 2022; 13():1035516. PubMed ID: 36523556
[TBL] [Abstract][Full Text] [Related]
9. Study of expression of GLUT-1 in oral potentially malignant disorders and oral squamous cell carcinoma: An immuno-histochemical analysis.
Attur SK; Patel A; Attur KM
J Oral Maxillofac Pathol; 2024; 28(1):70-76. PubMed ID: 38800421
[TBL] [Abstract][Full Text] [Related]
10. Glut-1 as a prognostic biomarker in oral squamous cell carcinoma.
Harshani JM; Yeluri S; Guttikonda VR
J Oral Maxillofac Pathol; 2014; 18(3):372-8. PubMed ID: 25948991
[TBL] [Abstract][Full Text] [Related]
11. GLUT-1 immunoexpression in oral epithelial dysplasia, oral squamous cell carcinoma, and verrucous carcinoma.
Angadi VC; Angadi PV
J Oral Sci; 2015 Jun; 57(2):115-22. PubMed ID: 26062860
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of glucose transporter-1 expression in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.
Patlolla P; N Shyam NDV; Kumar GK; Narayen V; Konda P; Mudududla P
J Oral Maxillofac Pathol; 2020; 24(3):578. PubMed ID: 33967505
[TBL] [Abstract][Full Text] [Related]
13. Predictive Prognostic Value of Tissue-Based MicroRNA Expression in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Troiano G; Mastrangelo F; Caponio VCA; Laino L; Cirillo N; Lo Muzio L
J Dent Res; 2018 Jul; 97(7):759-766. PubMed ID: 29533734
[TBL] [Abstract][Full Text] [Related]
14. Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study.
Panda A; Bandyopadhyay A; Mohiddin G; Raghuvanshi M; Sahoo SK; Bhuyan L
Niger J Surg; 2019; 25(2):203-207. PubMed ID: 31579378
[TBL] [Abstract][Full Text] [Related]
15. GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle.
Aerni-Flessner L; Abi-Jaoude M; Koenig A; Payne M; Hruz PW
Cardiovasc Diabetol; 2012 Jun; 11():63. PubMed ID: 22681646
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of GLUT-1 expression in oral squamous cell carcinoma: A prisma-compliant meta-analysis.
Li CX; Sun JL; Gong ZC; Lin ZQ; Liu H
Medicine (Baltimore); 2016 Nov; 95(45):e5324. PubMed ID: 27828852
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
Wiklund ED; Gao S; Hulf T; Sibbritt T; Nair S; Costea DE; Villadsen SB; Bakholdt V; Bramsen JB; Sørensen JA; Krogdahl A; Clark SJ; Kjems J
PLoS One; 2011; 6(11):e27840. PubMed ID: 22132151
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1.
Li X; Ren H
Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498
[TBL] [Abstract][Full Text] [Related]
19. Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review.
Lafuente Ibáñez de Mendoza I; Maritxalar Mendia X; García de la Fuente AM; Quindós Andrés G; Aguirre Urizar JM
J Periodontal Res; 2020 Jan; 55(1):13-22. PubMed ID: 31529626
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression.
Kim S; Park S; Oh JH; Lee SS; Lee Y; Choi J
BMC Oral Health; 2022 Sep; 22(1):378. PubMed ID: 36064348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
